Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Breast Neoplasms 3Prostatic Neoplasms 2Tooth, Impacted 1Sleep Initiation and Maintenance Disorders 1Resectable Colorectal Carcinoma 1Nocturia 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Hodgkin Disease 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Cancer Pain 1Agnosia 1

Interventions

Nivolumab 10Doxorubicin 10Cyclophosphamide 10Vinblastine 9Radiotherapy 8Dacarbazine 8Brentuximab Vedotin 8Bleomycin 7fludarabine phosphate 6fludarabine 6Prednisone 6Etoposide 6pembrolizumab 5Melphalan 5Whole-Body Irradiation 4Vincristine 4Mycophenolic Acid 4Filgrastim 4Tacrolimus 3Radiation 3Prednisolone 3Peripheral Blood Stem Cell Transplantation 3Granulocyte Colony-Stimulating Factor 3Busulfan 3Thiotepa 2Sirolimus 2Procarbazine 2Mechlorethamine 2Bendamustine Hydrochloride 2tislelizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Hodgkin Disease × Acupuncture Therapy × Clear all
NCT04459416 2025-10-20

Managing Pain and Symptom Burden Caused by Chemotherapy in People With Myeloma or Lymphoma

Memorial Sloan Kettering Cancer Center

Phase 3 Active not recruiting
299 enrolled 11 charts
LymphoidPlasma cell

Agnosia, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡